Skip to main content

Renal Cancer

Current Status and Innovations

  • Book
  • © 2022

Overview

  • Provides a carefully structured insight into the latest developments in renal cancer diagnostics and treatment
  • Contains clear guidance on the use of hybrid, real and virtual simulation techniques
  • Features key points and diagrams to reinforce fundamental aspects

This is a preview of subscription content, log in via an institution to check access.

Access this book

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

eBook USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

About this book

Renal Cancer: Current Status and Innovations provides a useful guide to the fundamental basics and latest diagnostic and treatment techniques for Renal Cancer. It features clearly structured and easy-to-understand chapters enabling the reader to develop a thorough understanding of screening, surveillance, diagnostics, pathology, robotic and open surgical approaches, ablation, medical treatment, psychology, and future innovations.

 The book provides a valuable resource for the full spectrum of clinicians involved in the multidisciplinary management of Renal Cancer.


Keywords

Table of contents (23 chapters)

Editors and Affiliations

  • Department Urology, St Georges University Hospital NHS Foundation Trust, London, UK

    Christopher Anderson

  • Department Uro-Oncology, St Georges University Hospital NHS Foundation Trust, London, UK

    Mehran Afshar

About the editors

Mr Christopher Anderson is a Consultant Urological Surgeon with a specialist interest in Renal and Prostate cancer. He has particular expertise in minimally invasive surgical approaches. He was an early adopter of laparoscopy and also an integral member of the team of Urologists who pioneered robotic surgery introducing it to the UK in 2005. He was the first surgeon to perform Laparoscopic Cryotherapy in the UK in 2004 and accrued a large cohort of such patients with long term follow up. He completed his undergraduate training at Stellenbosch University and his postgraduate training at Cape Town University South Africa and commenced a substantive Consultant post at St George's University Hospital in London in 1999. His early training in Laparoscopy and Robotic surgery took him on fellowships to Cleveland Clinic (Ohio), Jackson Memorial Hospital (Miami) and Henry Ford Hospital (Detroit) as well as  University Hospital of Leipzig (Germany). In the early years of Laparoscopicdevelopment He was a Trainer at Laparoscopic courses in Germany at Aesculap Academy Tuttlingen and Charite Hospital Berlin where he trained numerous UK and European Urologists. He was subsequently a Proctor to many UK Urologists in the field of Robotics. He has numerous peer review publications to his name and is an active clinical researcher in his field. He is a high volume surgeon and has built up a comprehensive tertiary referral Renal Cancer Service at St Georges Hospital. He is a passionate family man with whom he enjoys his musical and sporting interests.    


Dr Mehran Afshar, PhD, MB BS(Lond), MRCP(UK), PGDip(Onc), is a consultant oncologist at St George's University Hospitals, London, UK, specializing in the management of urological malignancies; he is also the Clinical Lead for Acute Oncology Services and Lead for Undergraduate Education in Oncology. He is an honorary Senior Lecturer at St Georges, University of London. He studied medicineat Barts & The Royal London School of Medicine and Dentistry, London (MBBS 2001), and completed his PhD in urologic oncology at Warwick University, Warwick, UK. Dr Afshar’s research interests include big data research, cancer informatics, biomarkers in cancer, and psycho-oncology, focusing on prostate, bladder, kidney, and penile cancers. He believes in a multi-faceted approach to cancer research and the care of the patient with cancer, integrating scientific, holistic, and technological interventions into an overarching therapeutic paradigm. He currently has over 50 publications and international presentations in his specialist fields. A number of his clinical works have achieved national and international acclaim with over 400 press articles in news outlets across 4 continents. 


 



Bibliographic Information

  • Book Title: Renal Cancer

  • Book Subtitle: Current Status and Innovations

  • Editors: Christopher Anderson, Mehran Afshar

  • DOI: https://doi.org/10.1007/978-3-030-84756-2

  • Publisher: Springer Cham

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer Nature Switzerland AG 2022

  • Hardcover ISBN: 978-3-030-84755-5Published: 12 April 2022

  • Softcover ISBN: 978-3-030-84758-6Published: 13 April 2023

  • eBook ISBN: 978-3-030-84756-2Published: 11 April 2022

  • Edition Number: 1

  • Number of Pages: VIII, 264

  • Number of Illustrations: 3 b/w illustrations, 43 illustrations in colour

  • Topics: Surgery, Oncology, Nephrology, Urology

Publish with us